Addressing the Potential Risks Associated with Ephedra Use: A Review of Recent Efforts

Public Health Reports

Volumn 118, Issue 6, 2003, Pages 487-492

  Schulman, Sara ^a,b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b HHS/OIG/OEI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRA EXTRACT;

ANXIETY; DEATH; DIET SUPPLEMENTATION; DRUG FATALITY; DRUG MARKETING; EPHEDRA; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPERTENSION; NAUSEA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAFETY; SEIZURE; STROKE; TREMOR; VOMITING;

EID: 0242642000     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3549(04)50284-4     Document Type: Article

References (25)

1. Khatcherresian LA. Regulation of dietary supplements: five years of DSHEA. Food Drug Law J 1999;54:623-44.
2. U.S. Consumer Supplement Use Summary 2001. Courtesy of Nutrition Business Journal.
3. Dietary Supplement Education Alliance. All dietary supplements [cited 2003 Sep 1]. Available from: URL: http://content.intramedicine.com/dse/consumer/dsmain.asp?ctype=ds
4. Widespread ignorance of regulation and labeling of vitamins, minerals and food supplements, according to a national Harris Interactive survey. Health Care News 2002 Dec 23 [cited 2003 Sep 1]. Available from: URL: http://www.harrisinteractive.com/news/newsletters /healthnews/HI_HealthCareNews2002Vol2_Iss23.pdf
5. Soller RW. Regulation in the herb market: the myth of the "unregulated industry." HerbalGram 2000;49:64-7. Available from: URL: http://www.herbalgram.org /herbalgram/articlesview.asp?a=2266
6. Adulterated food, 21 U.S.C. 342(f) (1996) [cited 2003 Sep 1]. Available from: URL: http://www4.law.cornell .edu/uscode/21/342.html
7. Wolfe SM. Statement before the National Academy of Sciences on the Framework for Evaluating the Safety of Dietary Supplements. 2001 Oct 11 [cited 2003 Sep 1]. Available from: URL: http://www.citizen.org/publications /release.cfm?ID=7091
8. Food and Drug Administration (US). Evidence on the safety and effectiveness of ephedra: implications for regulation [cited 2003 Sep 1]. Available from: URL: http://www.fda.gov/bbs/topics/NEWS/ephedra /whitepaper.html
9. Ephedra survey results: 1995-1999 [cited 2003 Sep 1]. Available from: URL: http://www.ephedrafacts.com /SuveyV6.PDF
10. Shakelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537-45.
11. DeVise D. Report: ephedra found in Bechler. Miami Herald 2002 Mar 14; p.1D.
12. General Accounting Office (US). Dietary supplements containing ephedra: health risks and FDA's oversight. Testimony before the House Subcommittee on Oversight of and Investigations (July 23, 2003) [cited 2003 Sep 1]. Available from: URL: http://www.gao.gov/
13. Walker A. The relation between voluntary notification and material risk in dietary supplement safety [cited 2003 Sep 1]. Available from: URL: http://icommons .harvard.edu/~hsph-epi221-01/Readings/04Dealingw Limitations/Voluntary_Notification_and_Actual_Risk .pdf
14. General Accounting Office (US). Dietary supplements: review of health-related call records for users of Metabolife 365. GAO-03-494 [cited 2003 Sep 1]. Available from: URL: http://www.gao.gov/
15. Jekel JF, Elmore JG, Katz DL. Epidemiology, biostatistics and preventive medicine. Philadelphia: W.B. Saunders, 1996. p. 56-8.
16. Samenuk D, Link MS, Homoud MK, Contreras R, Theoharides TC, Wang PJ, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-6.
17. FDA analysis of FDA data 1/93-2/01. Attachment I to Sep 5, 2001, petition by Public Citizen Health Research Group [cited 2003 May 15]. Available from: URL: http:// www.fda.gov/ohrms/dockets/dailys/01/Sep01/091001 /cp00001.pdf
18. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med 2003;138:468-71. [See also Correction: the relative safety of ephedra compared with other herbal products, Ann Intern Med 2003;138:1012.]
19. Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med 2003;138:468-71. [See also Correction: the relative safety of ephedra compared with other herbal products, Ann Intern Med 2003;138:1012.]
20. Haller CA, Benovitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
21. Kimmel SE. Summary of incidence of seizures, strokes, and myocardial infarctions in the population and estimations of risk in the population from ephedra products [cited 2003 May 15]. Available from: URL: http:// www.ephedrafacts.com/2.html
22. Department of Health and Human Services, Office of Inspector General. Dietary supplement labels: an assessment. OEI-01-01-00121 [cited 2003 Sep 1]. Available from: URL: http://oig.hhs.gov/oei/reports/oei/reports /oei-01-01-00121.pdf
23. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 2000;57:963-9.
24. Ephedra: guidelines for dosage and label warnings [cited 2003 May 18]. Available from: URL: http://www .supplementquality.com/safety/ephedra_safety_ warning.html
25. Department of Health and Human Services (US). Dietary supplements containing ephedrine alkaloids; reopening of the comment period. Docket no. 95N-0304 [cited 2003 Sep 1]. Available from: URL: http://www.fda.gov/OHRMS/DOCKETS/98fr/95n-0304-npr0003.pdf